CD8A and neoplasm: Using multi-parameter analysis of immune checkpoints such as PD-L1, CD8, and FOXP3 to study the interactions between cell types can provide a more comprehensive immune phenotype in the tumor microenvironment and help predict prognosis and precise treatment.